Tiny Molecules Set To Play Big Part In Lung Cancer Treatment
Fresh studies have aimed at secluding a tiny molecule that might in effect, be a big combater of a typical kind of lung cancer. Such cancer is found in people that have no history of smoking and heralds a new age for treating the dreaded malignant cells.
The microRNA miR-21 was especially heightened in adenocarcinomas hitting non-smokers; mainly those who have tested positive for mutations pertaining to epidermal growth factor receptor gene. Each year, one tenth of lung cancer sufferers happen to be people who never touched cigarettes.
Researchers from America and Japan who have indulged in this study are strong in conviction that miR-21 protein is not only a sign of the disease akin to PSA levels for prostrate cancer screenings, but also contributor of the disease.
Medical fraternity has long believed that there is a huge difference between those people who have never smoked and those who have been smoking in terms of acquiring lung cancer. Among people who have never smoked, adenocarcinomas happens to be the most common type of lung cancer. It is a type of non-small cell cancer, which can occur in some higher mammals, including humans. Non-small cell carcinoma is by far the most common type of lung cancer in US.
Scientists have tested cancer samples from some 28 patients, all non-smoking ones and suffering from adenocarcinoma. In comparison to those samples that had been taken from smokers, suffering from the same disease, miR-21 was present in a very heightened form in those patients who had never smoked all life.
MiR-21 is also present in heightened amount in those people who have adenocarcinomas pertaining to tobacco intake, but to a lesser extent. Research conducted earlier clearly suggested that miR-21 and microRNAs were signs of bad survival percentage for lung cancer caused by smoking.
Lung carcinoma in all forms is very difficult to be cured. Less than one tenth of people survive for five years after being attacked by the disease. 160000 Americans die of the curse each year. This makes the researchers pretty enthused on finding anything that helps them target a therapy on the cancer cells. Dr. Lichtenfeld, deputy chief medical officer of the American Cancer Society, further suggested the finding shows that there are plenty of reasons to believe that adenocarcinomas for non-smoker exhibiting miR-21 elevation could be treated.